Prevalence of Cardiovascular Disease in Patients with Ankylosing Spondylitis: An Analysis from a Nationwide Thailand Healthcare Database
Article Sidebar
Main Article Content
Abstract
Background: Chronic inflammation of Ankylosing spondylitis (AS) may be associated with cardiovascular disease (CVD). However, the association remains controversial.
Objectives: To determine whether patients with AS are at risk for CVD and the impact of atherosclerosis risk disease in AS.
Methods: We conducted a descriptive study based on a nationwide Thailand healthcare database, using ICD-10 of AS (M45). CVD was defined as either myocardial infarction (MI) (I20-I25), stroke (G45, I63, I69), peripheral arterial disease (I74), heart failure (HF) (I50), cardiomyopathy (I42), aortic valve disease (I35) or arrhythmia (I44). Atherosclerosis risk diseases were defined as either diabetes mellitus (DM) (E10, E11, E13), Hypertension (HT) (I10, I15), or dyslipidemia (DLD) (E78). A total of 766 hospitalized AS patients were included in the analysis. The odds ratio (OR) was calculated to define the risk of CVD and atherosclerosis risk disease.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
(ใส่ข้อความเดียวกันกับ ก๊อปปี้ไลน์ก็ได้)ดูตัวอย่างได้ที่หน้าบทความ---บทความนี้ตีพิมพ์เป็นลิขสิทธื์ของใคร...
References
Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007 Apr 21;369(9570):1379-1390. doi: 10.1016/S0140-6736(07)60635-7. PMID: 17448825.
Mathieu S, Pereira B, Soubrier M. Cardiovascular events in ankylosing spondylitis: an updated meta-analysis. Semin Arthritis Rheum. 2015 Apr;44(5):551-555. doi: 10.1016/j.semarthrit.2014.10.007. Epub 2014 Oct 18. PMID: 25455683.
Mathieu S, Soubrier M. Cardiovascular events in ankylosing spondylitis: a 2018 meta-analysis. Ann Rheum Dis. 2019 Jun;78(6):e57. doi: 10.1136/annrheumdis-2018-213317. Epub 2018 Mar 9. PMID: 29523520.
Bengtsson K, Forsblad-d’Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH. Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden. Ann Rheum Dis. 2018 Apr;77(4):541-548. doi: 10.1136/annrheumdis-2017-212189. Epub 2017 Dec 19. PMID: 29259045.
Ozkan Y. Cardiac Involvement in Ankylosing Spondylitis. J Clin Med Res. 2016 Jun;8(6):427-30. doi: 10.14740/jocmr2488w. Epub 2016 May 25. PMID: 27222669; PMCID: PMC4852774.
Aviña-Zubieta JA, Chan J, De Vera M, Sayre EC, Choi H, Esdaile J. Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study. Ann Rheum Dis. 2019 Apr;78(4):480-485. doi: 10.1136/annrheumdis-2018-214388. Epub 2019 Feb 8. PMID: 30737222.
Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, Jullien D, Aractingi S, Aubin F, Joly P, Le Maître M, Ortonne JP, Paul C, Richard MA. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013 Aug;27 Suppl 3:12-29. doi: 10.1111/jdv.12163. PMID: 23845149.
Peluso R, Caso F, Tasso M, Ambrosino P, Dario Di Minno MN, Lupoli R, Criscuolo L, Caso P, Ursini F, Puente AD, Scarpa R, Costa On Behalf Of CaRRDs Study Group L. Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients. Rev Recent Clin Trials. 2018;13(3):199-209. doi: 10.2174/1574887113666180314105511. PMID: 29542417; PMCID: PMC6691775.
Arida A, Protogerou AD, Konstantonis G, Konsta M, Delicha EM, Kitas GD, Sfikakis PP. Subclinical Atherosclerosis Is Not Accelerated in Patients with Ankylosing Spondylitis with Low Disease Activity: New Data and Metaanalysis of Published Studies. J Rheumatol. 2015 Nov;42(11):2098-105. doi: 10.3899/jrheum.150316. Epub 2015 Oct 1. PMID: 26428207.
Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality: A Population-Based Study. Ann Intern Med. 2015 Sep 15;163(6):409-16. doi: 10.7326/M14-2470. PMID: 26258401.
Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology (Oxford). 2020 Oct 1;59(Suppl4):iv47-iv57. doi: 10.1093/rheumatology/keaa246. PMID: 33053193; PMCID: PMC7566561.
Essers I, Stolwijk C, Boonen A, De Bruin ML, Bazelier MT, de Vries F, van Tubergen A. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis. 2016 Jan;75(1):203-9. doi: 10.1136/annrheumdis-2014-206147. Epub 2014 Oct 31. PMID: 25362044.
Moyssakis I, Gialafos E, Vassiliou VA, Boki K, Votteas V, Sfikakis PP, Tzelepis GE. Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis. Scand J Rheumatol. 2009 May-Jun;38(3):216-21. doi: 10.1080/03009740802474672. PMID: 19229673.
Heslinga SC, Van Dongen CJ, Konings TC, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, Nurmohamed MT. Diastolic left ventricular dysfunction in ankylosing spondylitis--a systematic review and meta-analysis. Semin Arthritis Rheum. 2014 Aug;44(1):14-9. doi: 10.1016/j.semarthrit.2014.02.004. Epub 2014 Feb 14. PMID: 24655534.
Brunner F, Kunz A, Weber U, Kissling R. Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol. 2006 Feb;25(1):24-9. doi: 10.1007/s10067-005-1117-6. Epub 2005 Oct 25. PMID: 16247583.